ֲý

Joel D. Temple, MD

Physician

ֲý Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803

Biography

Dr. Joel D. Temple is director of electrophysiology, a pediatric cardiologist, frequently invited lecturer and author of more than a dozen abstracts and journal articles. He's a member of the American Medical Association, American College of Cardiology, Heart Rhythm Society and Pediatric Electrophysiology Society. His research work revolves around the catheter ablation of arrhythmias and the management of complex congenital arrhythmias.

Fellowship

  • Pediatric Cardiology - Vanderbilt University Medical Center, 2001

Internship

  • Pediatrics - Portsmouth Naval Medical Center, 1992

Residency

  • Pediatrics - Portsmouth Naval Medical Center, 1994

Medical/Dental School

  • MD - University of Chicago, Pritzker School of Medicine, 1991

Board Certifications

  • American Board of Pediatrics/Pediatric Cardiology

  • Transesophageal pacing studies reduce readmission but prolong initial admission in infants with supraventricular tachycardia: A cost-comparison analysis; Heart Rhythm O2; (2023).

  • Familial Recurrence Patterns in Congenitally Corrected Transposition of the Great Arteries: An International Study; Circulation: Genomic and Precision Medicine; (2022).

  • Sudden cardiac death in children and young adults without structural heart disease: A comprehensive review; Reviews in Cardiovascular Medicine; (2020).

  • Identification of a Novel Homozygous Multi-Exon Duplication in RYR2 among Children with Exertion-Related Unexplained Sudden Deaths in the Amish Community; JAMA Cardiology; (2020).

  • Molecular characterization of the calcium release channel deficiency syndrome; JCI Insight; (2020).

  • Significance of automated external defibrillator in identifying lethal ventricular arrhythmias; European Journal of Pediatrics; (2019).

  • Reply to correspondence article, correspondence on “Significance of automated external defibrillator in identifying lethal ventricular arrhythmias”; European Journal of Pediatrics; (2019).

  • The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: Findings from an international multicentre registry; Europace; (2018).

  • Clinical Outcomes and Modes of Death in Timothy Syndrome: A Multicenter International Study of a Rare Disorder; JACC: Clinical Electrophysiology; (2018).

  • Impact of pharmacist intervention on electrocardiogram monitoring of pediatric patients on multiple QTc interval–prolonging medications; Journal of Pediatric Pharmacology and Therapeutics; (2017).

  • Development and impact of arrhythmias after the Norwood procedure: A report from the Pediatric Heart Network; Journal of Thoracic and Cardiovascular Surgery; (2017).

  • Catecholaminergic Polymorphic Ventricular Tachycardia in Children: Analysis of Therapeutic Strategies and Outcomes from an International Multicenter Registry; Circulation: Arrhythmia and Electrophysiology; (2015).

  • Predicting Utility of Exercise Tests Based on History/Holter in Patients with Premature Ventricular Contractions; Pediatric Cardiology; (2015).

  • Resynchronization therapy in pediatric and congenital heart disease patients: An international multicenter study; Journal of the American College of Cardiology; (2005).

  • Atrial fibrillation in KCNE1-null mice; Circulation Research; (2005).

  • Radiofrequency ablation of a left-sided atrioventricular pathway in a patient with Marfan syndrome; Cardiology in the Young; (2002).

  • Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes; Circulation; (2002).

  • Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy; Circulation; (2002).